Normal view MARC view ISBD view

The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: comment.

Tripodi, A

The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: comment. [electronic resource] - Journal of thrombosis and haemostasis : JTH 09 2017 - 1882-1883 p. digital

Publication Type: Letter; Comment

ISSN: 1538-7836

Standard No.: 10.1111/jth.13750 doi

Subjects--Topical Terms:
Antibodies, Monoclonal, Humanized
Antithrombins
Dabigatran

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)